DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avonex (Interferon Beta-1A) - Current Clinical Trials

 
 



Avonex Related Clinical Trials

Immunogenicity and Safety Study of Serum-Free Avonex [Completed]

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers [Completed]

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe [Completed]

Evaluate the Safe and Effective Use of the Avonex´┐Ż Single-Use Autoinjector in Multiple Sclerosis Subjects [Completed]

Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) [Completed]

Pregnancy Exposure Registry for Avonex (Interferon Beta-1a) [Completed]

Open-Label Safety Extension Study of Avonex [Completed]

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis [Completed]

Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis [Completed]

A Study of Rebif« Compared With Avonex« in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) [Completed]

A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex« in Chinese Healthy Volunteer Subjects [Completed]

Avonex«: Safety, Blood Levels and Effects [Completed]

Open Label Study of Tolerability, PK and PD of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif« and Avonex« in Healthy Volunteers [Active, not recruiting]

How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose [Terminated]

A Phase 2 Study of Interferon Beta-1a (Avonex«) in Ulcerative Colitis [Completed]

Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients [Terminated]

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS [Completed]

A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease [Completed]

Assessing Tolerability of Avonex Intramuscular Injections [Completed]

Supplementation of VigantOL´┐Ż Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif´┐Ż Treatment [Completed]

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Completed]

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif´┐Ż New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. [Completed]

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy [Completed]

A Study of Avonex« to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers [Completed]

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers [Completed]

Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis [Completed]

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? [Completed]

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif« [Completed]

Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex [Active, not recruiting]

AVONEX« Combination Trial - "ACT" [Completed]

A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a [Withdrawn]

Phase I BP Interferon (IFN) Beta-004 [Completed]

A Study of Rebif« in Subjects With Relapsing Multiple Sclerosis [Recruiting]

Retrospective Cohort Study of Rebif« Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY) [Completed]

Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta [Completed]

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif [Completed]

A Study to Evaluate Rebif« New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis [Completed]

Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis [Completed]

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis [Completed]

Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a [Active, not recruiting]

Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis [Completed]

Canadian Avonex PEN Productivity Study [Completed]

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis [Recruiting]

Phase I BP Interferon (IFN) Beta-001 [Completed]

Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) [Completed]

Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis [Not yet recruiting]

Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis [Completed]

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS) [Enrolling by invitation]

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis [Completed]

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif [Enrolling by invitation]

A Prospective Study Looking at the Use of Rebif« in Subjects With Clinically Isolated Syndrome [Completed]

Safety and Efficacy of Treatment With Interferon Beta-1a Rebif´┐Ż in Patients With Crohn's Disease [Terminated]

A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 ┬Ág 3 Times Weekly [Active, not recruiting]

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis [Completed]

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis [Completed]

Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif´┐Ż) in Relapsing-Remitting Multiple Sclerosis [RRMS] [Terminated]

Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx [Completed]

Safety Study of Interferon Beta 1a to for Acute Stroke [Completed]

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial [Completed]

REbif FLEXible Dosing in Early Multiple Sclerosis (MS) [Completed]

Rebif´┐Ż Versus Copaxone´┐Ż in the Treatment of Relapsing Remitting Multiple Sclerosis [Completed]

Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients [Recruiting]

COMPliance With Avonex« PS in Patients With Relapsing-Remitting MS [Completed]

A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects [Completed]

RNF and Betaseron´┐Ż Tolerability Study [Completed]

Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis [Withdrawn]

Controlled High Risk AVONEX« Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance [Terminated]

Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study [Active, not recruiting]

EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis [Completed]

Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS [Recruiting]

Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control [Completed]

Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies [Completed]

Oral Cladribine in Early Multiple Sclerosis (MS) [Completed]

The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment [Completed]

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis [Completed]

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis (MS) After Failure on Other Therapies [Recruiting]

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis [Active, not recruiting]

Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis [Completed]

A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis [Completed]

A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability [Withdrawn]

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. [Completed]

Biogen Multiple Sclerosis Pregnancy Exposure Registry [Recruiting]

Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015